Editorial: Diabetic kidney disease: Act now or pay later

Acta Diabetologica

Volumn 47, Issue 1, 2010, Pages 1-4

  Atkins, Robert C ^a   Zimmet, Paul ^b  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HUMAN; KIDNEY DISEASE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PRIORITY JOURNAL; SCREENING; CHRONIC KIDNEY FAILURE; MASS SCREENING; MEDICAL SOCIETY; METHODOLOGY; PRIMARY PREVENTION;

DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; MASS SCREENING; PRIMARY PREVENTION; SOCIETIES, MEDICAL;

EID: 76449102596     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0175-7     Document Type: Editorial

References (28)

1. International Diabetes Federation and International Society of Nephrology, Diabetes and kidney disease: time to act. 2003: Brussels
2. P Zimmet K Alberti J Shaw 2001 Global and societal implications of the diabetes epidemic Nature 414 782 787 10.1038/414782a 1:CAS:528: DC%2BD38Xhtlymtg%3D%3D 11742409 (Pubitemid 34000780)
3. H King R Aubert W Herman 1998 Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1414 1431 10.2337/diacare.21.9.1414 1:STN:280:DyaK1czpsVyluw%3D%3D 9727886
4. K Yoon, et al. 2006 Epidemic obesity and type 2 diabetes in Asia Lancet 368 1681 1688 10.1016/S0140-6736(06)69703-1 17098087 (Pubitemid 46048556)
5. Sicree R, Shaw J, Zimmet P (2006) Diabetes and impaired glucose tolerance. In: Gan D (ed) Diabetes atlas, 3rd edn. International Diabetes Federation, Brussels, pp 15-109
6. Reutens AT, Prentice L, Atkins R (2008) The epidemiology of diabetic kidney disease. In: Ekoé J et al (eds) The epidemiology of diabetes mellitus, 2nd edn. Wiley, Chichester, pp 499-518
7. National Institutes of Health, National Institute of Diabetes, Digestive, Kidney Diseases (2007) International comparisons, in annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, pp 239-254
8. McDonald S, Excell L, Livingston B (eds) (2008) Appendix II, in ANZDATA Registry Report 2008. Australia and New Zealand Dialysis and Transplant Registry, Adelaide, pp 1-97
9. K Yamagata, et al. 2008 Chronic kidney disease perspectives in Japan and the importance of urinalysis screening Clin Exp Nephrol 12 1 8 10.1007/s10157-007-0010-9 18175065
10. M Lysaght 2002 Maintenance dialysis population dynamics: current trends and long term implications J Am Soc Nephrol 13 S37 S40 11792760
11. A Adler, et al. 2003 Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 225 232 10.1046/j.1523-1755.2003.00712.x 12472787 (Pubitemid 35463925)
12. R Retnakaran, et al. 2006 Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74 Diabetes 55 6 1832 1839 10.2337/db05-1620 1:CAS:528:DC%2BD28Xlsl2gu7w%3D 16731850 (Pubitemid 44324140)
13. H Parving, et al. 2006 Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective Kidney Int 69 11 2057 2063 10.1038/sj.ki.5000377 16612330 (Pubitemid 43924271)
14. T Ninomiya, et al. 2009 Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes J Am Soc Nephrol 20 8 1813 1821 10.1681/ASN.2008121270 19443635
15. D Dunstan, et al. 2002 The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study Diabetes Care 25 5 829 834 10.2337/diacare.25.5.829 11978676 (Pubitemid 41094278)
16. S White, et al. 2008 Limited knowledge of kidney disease in a survey of AusDiab study participants Med J Aust 188 4 204 208 18279125
17. A Whaley-Connell, et al. 2009 Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) Am J Kidney Dis 53 Suppl 4 S11 S21 10.1053/j.ajkd.2009.01.004 1:CAS:528:DC%2BD1MXkslKgsbk%3D 19285607
18. M Thomas G Viberti P Groop 2008 Screening for chronic kidney disease in patients with diabetes: are we missing the point? Nat Clin Pract Nephrol 4 1 2 3 10.1038/ncpneph0679 18043592 (Pubitemid 350308224)
19. R Holman, et al. 2008 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 15 1577 1589 10.1056/NEJMoa0806470 1:CAS:528:DC%2BD1cXht1Wgt7nK 18784090
20. R Bilous 2008 Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabet Med 25 Suppl 2 25 29 10.1111/j.1464-5491.2008. 02496.x 18717975 (Pubitemid 352020092)
21. P Gaede, et al. 2008 Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 6 580 591 10.1056/NEJMoa0706245 1:CAS:528:DC%2BD1cXhs1entLc%3D 18256393 (Pubitemid 351214285)
22. A Patel, et al. 2007 Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 829 840 10.1016/S0140-6736(07)61303-8 1:CAS:528:DC%2BD2sXhtVWjs7zO 17765963 (Pubitemid 47362321)
23. AC Group, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 10.1056/NEJMoa0802987 (Pubitemid 351831357)
24. Zoungas S et al. (2009) The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care Aug 3 [Epub ahead of print]
25. P Ruggenenti, et al. 2004 Preventing microalbuminuria in type 2 diabetes N Engl J Med 351 19 1941 1951 10.1056/NEJMoa042167 1:CAS:528: DC%2BD2cXps1Wlt70%3D 15516697 (Pubitemid 39447135)
26. H Parving, et al. 2001 The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 12 870 878 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D 11565519 (Pubitemid 34940826)
27. E Lewis, et al. 2001 Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Eng J Med 345 851 860 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D (Pubitemid 34940824)
28. B Burney R Kalaitzidis G Bakris 2009 Novel therapies of diabetic nephropathy Curr Opin Nephrol Hypertens 18 2 107 111 10.1097/MNH. 0b013e3283249c51 1:CAS:528:DC%2BD1MXltVWrtr4%3D 19434047